Skip to content

Clinical trials

Completed COVID-19 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Status: Completed Country / region: South Korea Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
202022
202114
20223
20233
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)5
Cellid Co., Ltd.3
Celltrion3
Pfizer3
SK Bioscience Co., Ltd.3
Shin Poong Pharmaceutical Co. Ltd.3
Bukwang Pharmaceutical2
GeneOne Life Science, Inc.2
Gilead Sciences2
Seoul National University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1946
Coronavirus Infections3
Influenza, Human2
Colorectal Neoplasms1
Critical Illness1
Frailty1
Hemolysis1
Infections1
Kidney Failure, Chronic1
Neoplasms1

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.